The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients
2007

Onychomycosis in Hemodialysis Patients

Sample size: 109 publication Evidence: moderate

Author Information

Author(s): Kuvandik Güven, Çetin Meryem, Genctoy Gultekin, Horoz Mehmet, Duru Mehmet, Akcali Cenk, Satar Salim, Kiykim Ahmet A, Kaya Hasan

Primary Institution: Mustafa Kemal University, Faculty of Medicine

Hypothesis

What is the prevalence of onychomycosis among hemodialysis patients with and without diabetes mellitus?

Conclusion

The prevalence of dystrophic nail changes and onychomycosis is increased among hemodialysis patients, particularly those with diabetes mellitus.

Supporting Evidence

  • Onychomycosis was diagnosed in 26.6% of hemodialysis patients.
  • Diabetes mellitus was present in 68.9% of patients with onychomycosis.
  • Toenail scraping cultures were positive in 19.7% of patients with dystrophic nail changes.

Takeaway

This study found that many patients on dialysis have nail fungus, especially if they also have diabetes.

Methodology

109 hemodialysis patients were studied, with nail scrapings taken from those with dystrophic nail changes and examined for fungal infections.

Limitations

The study did not investigate the presence of peripheral vascular disease in patients.

Participant Demographics

35 females and 74 males; mean age: 54.6 ± 16.7 years.

Statistical Information

P-Value

0.009 for diabetes mellitus; 0.008 for duration of dialysis

Confidence Interval

1.417–11.424 for diabetes mellitus; 1.059–1.475 for duration of dialysis

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-7-102

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication